News and Announcements
Browse the articles below to learn more about our faculty’s latest achievements, awards and honors.
05.19.2022Dr. Amy Krambeck argues in favor of achieving stone-free status in all patients undergoing PCNL.
05.16.2022At the 2022 American Urological Association meeting, Dr. Mohammad Siddiqui and colleagues presented the results of their study investigating whether capsular ‘abutment’ on pre-operative mpMRI is an indication of prostate pathology in cancerous forms.
05.14.2022At the 2022 American Urological Association meeting, Nelson E. Bennett, MD, moderate a plenary session which analyzes the benefits and disadvantages of telemedicine in sexual medicine.
05.14.2022At the 2022 American Urological Association meeting, Dr. Huang and Justin Dubin, MD, investigated the quality of information for testosterone therapy on social media channels with their respective studies.
05.14.2022Adam B. Murphy, MD, MBA, MSCI, discusses the background and rationale for the study, “Vitamin D has a stronger impact on prostate tumor gene expression in Black men,” which he presented at the 2022 American Urological Association annual meeting in New Orleans.
05.13.2022Northwestern Medicine investigators have identified a gene that confers resistance to a common prostate cancer treatment, according to a study published in Cancer Research.
05.06.2022Dr. Justin Dubin, a Urology fellow specializing in male infertility and sexual medicine, provides insight into the association between getting the COVID infection and erectile dysfunction.
05.03.2022Urinary incontinence can plague men as they age, but a new study suggests it may be more than just a bothersome condition and might actually be a harbinger of early death. Dr. Anthony Schaeffer explains why he thinks the results may be statistically significant, but not clinically significant.
05.03.2022This year's grant recipient includes Stephanie J. Kielb, MD, for her work with the International Organization for Women & Development (IOWD).
04.22.2022Channa Amarasekera, MD, discusses the impact of the Gay and Bisexual Men’s Urology Program.
04.20.2022William J. Catalona, MD, explains why he believes the cancer label is necessary.
03.22.2022Edward M. Schaeffer, MD, PhD and Ashley E. Ross, MD, PhD, discuss the feasibility and outcomes of integrating transperineal prostate biopsy into the outpatient urologic clinic.
03.11.2022Dr. Channa Amarasekera talks about the development of the Gay and Bisexual Men’s Urology Program and explains what doctors can do to better support their gay and bisexual prostate cancer patients.
03.09.2022Stephanie Kielb, MD, discusses how disability associated with spinal injuries may strongly contribute to lower prostate cancer screening rates.
02.25.2022Ashley E. Ross, MD, PhD, reviews data and study results from the phase 3 TITAN and phase 3 ARCHES trial in mCSPC.
01.21.2022In an interview with 16 News Now, Amy Krambeck, MD discusses the benefits of holmium laser enucleation of the prostate with an upgraded MOSES laser as a surgical treatment for lower urinary tract symptoms related to benign prostatic hyperplasia (BPH).
- 01.06.2022William J. Catalona, MD, explains how prostate-specific antigen (PSA) testing revolutionized screening and treatment of prostate cancer.
01.05.2022Amy E. Krambeck, MD, discusses findings on the recent Urology Practice study, “The Economic Burden of Cystoscopy-Based Ureteral Stent Removal in the United States: An Analysis of Nearly 30,000 Patients.” She concluded that extraction strings may offer a safe and cost effective method for stent removals.
01.04.2022Channa Amarasekera, MD, discusses some of the challenges that sexual minorities face along with ways that clinicians can be more supportive towards this population of patients.
- 12.28.2021
Congratulations to Nelson E. Bennett, MD, Robert E. Brannigan, MD, William J. Catalona, MD, Shilajit D. Kundu, MD, Kent T. Perry, MD, Dennis Pessis, MD, and Edward M. Schaeffer, MD.
12.07.2021Dr. Channa Amarasekera discusses the new innovative Gay and Bisexual Men’s Urology Program and how it's filling an unmet need, and more.
10.20.2021From teasing out determinants of health disparities to developing precision medicine treatments, clinicians and scientists from the Lurie Cancer Center are dramatically changing the landscape for all men with prostate cancer.
- 09.24.2021
In an interview with Targeted Oncology, Ashley E. Ross, MD, PhD, discusses new prostate cancer screening and staging options as well as therapies for both earlier and later-stage disease.
09.13.2021Lurie Comprehensive Cancer Center of Northwestern University was awarded a five-year, $9.2 million grant renewal from the National Cancer Institute (NCI) for its continued leadership of a Specialized Programs of Research Excellence (SPORE) in Prostate Cancer.
Tumor-related risk factors affect conversion of active surveillance to treatment for prostate cancer09.10.2021Study by Dr. William J. Catalona assess the time to conversion from active surveillance to treatment for prostate cancer and provides new data on factors affecting the outcomes of this increasingly used management strategy.
08.23.2021Matthew T. Hudnall a resident in the department of Urology at Northwestern University Feinberg School of Medicine, discusses how terms used to describe prostate cancer could impact a patient`s subsequent decision-making, including preference for active surveillance.
08.23.2021New research shows that once past the age of 50, the likelihood of fathering a child appear to decline, even with assisted reproductive technology. Featuring Dr. Robert Brannigan.
- 07.27.2021
Study by Dr. Murphy alters the understanding of how prognostic molecular assays that generate probabilities of poor outcome can impact treatment decisions in diverse populations.
06.27.2021Illinois state Rep. La Shawn Ford shares his prostate cancer journey along with the importance of early cancer screening. He also sheds some light on racial health disparities and urges for a greater understanding of health inequities.